Napredna pretraga

Pregled bibliografske jedinice broj: 813857

The Benefit and Future of Pharmacogenetics


Samardzic, Janko; Švob Štrac, Dubravka; van den Anker, Johannes N.
The Benefit and Future of Pharmacogenetics // Total Intravenous Anesthesia and Target Controlled Infusions. A Comprehensive Global Anthology / Absalom, Anthony R. ; Mason, Keira P. (ur.)., 2017. str. 697-711


Naslov
The Benefit and Future of Pharmacogenetics

Autori
Samardzic, Janko ; Švob Štrac, Dubravka ; van den Anker, Johannes N.

Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, pregledni

Knjiga
Total Intravenous Anesthesia and Target Controlled Infusions. A Comprehensive Global Anthology

Urednik/ci
Absalom, Anthony R. ; Mason, Keira P.

Izdavač
Springer International Publishing

Godina
2017

Raspon stranica
697-711

ISBN
978-3-319-47607-0

Ključne riječi
Pharmacogenetics ; total intravenous anesthesia ; therapeutic drug efficacy ; adverse drug reactions

Sažetak
In recent years pharmacogenetics has received major attention in many areas of medicine, giving the potential basis of precision medicine in the near future. Determination of genetic factors of prognostic value for a target drug choice and dosing regimen will improve the safe and effective use of medicines in patients of all ages. Individual differences in pharmacological responses might lead to serious clinical problems such as difficulties in reaching optimal efficacy, appearance of drug interactions and adverse drug reactions (ADRs). Based upon the current knowledge, it is clear that an early adjustment of a therapy regimen using genetic characteristics of a patient can help prevent some of these side effects. Thus, the application of pharmacogenetics might have a great potential in helping providers to reduce and prevent ADRs and to improve therapeutic drug efficacy .

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove
Institut "Ruđer Bošković", Zagreb

Autor s matičnim brojem:
Dubravka Švob Štrac, (258591)